Wutah dodolan triwulanan Guardant Health, Inc. (GH)

Simbol lan logo merek Guardant Health Inc (GH)

Guardant Health, Inc. (GH) is a leading innovator in liquid biopsy, bringing together elite geneticists to save lives. A robust patent portfolio provides the company with a technological edge and protects its market share. Strategic alliances with pharmaceutical behemoths accelerate the launch of clinical tests. The quarterly revenue growth rate demonstrates business dynamics, where the current level is approximately 35.60, helping investors identify the asset's development phase in advance.

GH (Guardant360) riwayat Wutah pendapatan triwulanan saka 04.07.2022 nganti 20.11.2026

Rincian metrik keuangan lan pasar Guardant Health (GH)

- rega saham lan target rega konsensus:
Analisis kabeh metrik perusahaan:GH - Guardant Health
Produk sing diprodhuksi guardanthealth.com

Guardant Health, Inc. (GH) maintains its leadership in oncology by scaling liquid biopsy for targeted therapy. By analyzing quarterly revenue growth rates, investors assess operational sales dynamics adjusted for fiscal factors, where the current value of 35.60 serves as an indicator of market adoption and determines the risk of capital drawdown should business expansion slow.